Assessing the Turkish DDIVAT for Visual Acuity Measurement

NCT ID: NCT07240480

Last Updated: 2025-12-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-12-01

Study Completion Date

2026-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational methodological study is to validate the Turkish version of the DDIVAT visual acuity measuring device in a Turkish-speaking adult population.

The main questions it aims to answer are:

Does the Turkish version of the DDIVAT provide reliable and valid visual acuity measurements in Turkish speakers?

Are the results of the DDIVAT comparable to those obtained with the standard Snellen chart used in clinical practice?

Researchers will compare DDIVAT visual acuity test results with Snellen chart results to see if both methods produce consistent measurements.

Participants will:

Be adults aged 18 years or older, including both patients and healthy volunteers.

Undergo visual acuity testing using the DDIVAT system displayed on a smart TV connected to the university server.

Have their visual acuity re-measured using the standard Snellen optotype under the same conditions.

No medication or invasive procedure will be used. The study carries no risk to participants.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is a non-interventional, observational methodological validation study designed to evaluate the validity and reliability of the Turkish version of the DDIVAT (Digital Distance Interactive Visual Acuity Test) in a Turkish-speaking population.

The DDIVAT visual acuity test was originally developed and validated at Democritus University of Thrace (Greece) and has been approved by the National Medicines Organization as a Class I medical device. The current study aims to determine whether the Turkish-translated version of this visual acuity measurement tool performs consistently and accurately among Turkish-speaking participants.

Visual acuity is one of the most fundamental components of a comprehensive ophthalmological examination. It measures the clarity or sharpness of vision, which can be influenced by refractive errors and a variety of ocular diseases. Accurate and accessible tools for measuring visual acuity are therefore essential in both clinical and research settings.

In this study, 200 adult participants (aged 18 years and older) will be recruited from Trakya University Hospital, Department of Ophthalmology (Edirne, Türkiye). The study population will include both healthy volunteers and patients presenting to the ophthalmology clinic.

Each participant will undergo two visual acuity measurements under standardized conditions:

DDIVAT visual acuity test (Turkish version), administered via a smart TV connected to the university's secure server.

Snellen chart test, which represents the standard clinical practice currently used at Trakya University Hospital.

Measurements will be taken monocularly (each eye tested separately) while participants wear their current optical correction (e.g., eyeglasses or contact lenses).

The study will compare the two measurement methods to determine:

The level of agreement between DDIVAT and Snellen test results.

The test-retest reliability of the Turkish DDIVAT.

Since no medication, invasive procedure, or experimental intervention will be applied, the study poses no potential risk to participants. All procedures will comply with the Declaration of Helsinki, Good Clinical Practice (GCP) principles, and relevant data protection regulations.

Collected data will be stored anonymously and used solely for research purposes. The findings are expected to provide evidence supporting the use of DDIVAT as a reliable digital visual acuity tool for Turkish-speaking populations, enhancing accessibility and standardization of visual testing in both clinical and teleophthalmology contexts.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Visual Acuity Refractive Errors Myopia Hyperopia Astigmatism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Participants Undergoing Visual Acuity Testing

All enrolled participants (n = 200) will complete two visual acuity measurements during a single visit: one using the DDIVAT (Digital Device Independent Visual Acuity Test) Turkish version and one using the standard Snellen chart. The study compares the agreement and test-retest reliability of these two methods. No intervention, medication, or treatment is applied.

DDIVAT Visual Acuity Test (Turkish Version)

Intervention Type DIAGNOSTIC_TEST

Participants' visual acuity will be measured using the Turkish version of the DDIVAT digital visual acuity device and compared with Snellen chart results. No treatment or invasive procedure will be performed.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

DDIVAT Visual Acuity Test (Turkish Version)

Participants' visual acuity will be measured using the Turkish version of the DDIVAT digital visual acuity device and compared with Snellen chart results. No treatment or invasive procedure will be performed.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults aged 18 years or older

Turkish-speaking individuals able to understand the study purpose

Willingness to participate and provide written informed consent

Participants with or without refractive errors (e.g., myopia, hyperopia, astigmatism)

Exclusion Criteria

* Age below 18 years

Individuals unable to complete visual acuity testing

Presence of severe ocular pathology (e.g., corneal opacity, retinal detachment) that prevents accurate measurement

Cognitive or communication difficulties preventing informed consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Trakya University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Prof. Dr. Hande Guclu

Department Head - Ophthalmology (Trakya Univ.)-Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hande Güçlü, M.D., Prof. Dr.

Role: PRINCIPAL_INVESTIGATOR

Trakya University Faculty of Medicine Hospital

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Tuğçe Bek, M.D.

Role: CONTACT

+90 533 560 2583

Ahmet Kaan Şimşek, Md.

Role: CONTACT

+90 534 323 3010

References

Explore related publications, articles, or registry entries linked to this study.

Posar A, Visconti P. Early Motor Impairment in Children with Autism Spectrum Disorder. Turk Arch Pediatr. 2021 Nov;56(6):646-647. doi: 10.5152/TurkArchPediatr.2021.21168. No abstract available.

Reference Type BACKGROUND
PMID: 35110066 (View on PubMed)

Daiber HF, Gnugnoli DM. Visual Acuity. 2023 May 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK563298/

Reference Type BACKGROUND
PMID: 33085445 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://ddivat.med.duth.gr/DDiVAT/welcome.html

Official site of the DDIVAT (Digital Device Independent Visual Acuity Test) developed at Democritus University of Thrace, Greece.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Turkish DDIVAT TrakyaUni

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Astigmatism Post-trabeculectomy
NCT01711190 COMPLETED
Myopia Prevention With Reading Glasses
NCT05030103 NOT_YET_RECRUITING NA